株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

世界のヒト微生物叢 (ヒトマイクロバイオーム) 市場:製品、用途、疾患、技術、地域別の予測

Global Human Microbiome Market Size study, by Product, By Application, By Disease, By Technology and Regional Forecasts 2019-2026

発行 Bizwit Research & Consulting LLP 商品コード 917694
出版日 ページ情報 英文
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=109.83円で換算しております。
世界のヒト微生物叢 (ヒトマイクロバイオーム) 市場:製品、用途、疾患、技術、地域別の予測 Global Human Microbiome Market Size study, by Product, By Application, By Disease, By Technology and Regional Forecasts 2019-2026
出版日: 2019年11月28日 ページ情報: 英文
概要

当レポートは世界のヒト微生物叢 (ヒトマイクロバイオーム) 市場について調査しており、市場成長要因、機会や課題、製品・用途・疾患・技術・地域別の市場分析、競合情勢、主要企業のプロファイル等の情報を提供しています。

目次

第1章 エグゼクティブサマリー

  • 市場のスナップショット
  • 市場推計および予測:全体/セグメント別
    • 製品別
    • 用途別
    • 疾患別
    • 技術別
    • 地域別
  • 主な動向
  • 推計方法
  • 調査の前提条件

第2章 市場の定義および範囲

  • 調査の目的
  • 市場の定義・範囲
    • 調査範囲
    • タイプの進展
  • 調査のために考慮された年
  • 為替レート

第3章 市場力学

  • 市場の影響分析
    • 市場成長要因
    • 市場の課題
    • 市場機会

第4章 世界の市場分析

  • ポーターのファイブフォース分析
    • サプライヤーの交渉力
    • バイヤーの交渉力
    • 新規参入の脅威
    • 代替品の脅威
    • 業界内の競争
    • ポーターのファイブフォース分析の将来的アプローチ
  • PEST分析
    • 政治的
    • 経済的
    • 社会的
    • 技術的
  • 投資採用モデル
  • アナリストの提言・結論

第5章 市場分析:製品別

  • 市場のスナップショット
  • 市場実績:ポテンシャル分析
  • 市場の推計・予測
  • サブセグメント分析
    • プロバイオティクス
    • プレバイオティクス
    • 食品
    • 医療食品
    • 診断テスト
    • 薬物

第6章 市場分析:用途別

  • 市場のスナップショット
  • 市場実績:ポテンシャル分析
  • 市場の推計・予測
  • サブセグメント分析
    • 治療
    • 診断

第7章 市場分析:疾患別

  • 市場のスナップショット
  • 市場実績:ポテンシャル分析
  • 市場の推計・予測
  • サブセグメント分析
    • 感染症
    • 炎症性疾患
    • 内分泌・代謝障害
    • その他

第8章 市場分析:技術別

  • 市場のスナップショット
  • 市場実績:ポテンシャル分析
  • 市場の推計・予測
  • サブセグメント分析
    • ゲノミクス
    • プロテオミクス
    • メタボロミクス

第9章 市場分析:地域別

  • 市場のスナップショット
  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • その他
  • アジア太平洋地域
    • 中国
    • インド
    • 日本
    • その他
  • ラテンアメリカ
    • ブラジル
    • メキシコ
  • その他

第10章 競合情勢

  • 主な市場戦略
  • 企業プロファイル
    • Enterome Bioscience
    • Seres Therapeutics
    • 4D Pharma PLC
    • Ubiome, Inc.
    • E.I. Du Pont De Nemours and Company
    • Synlogic
    • Second Genome
    • Vedanta Biosciences, Inc.
    • Ferring Pharmaceuticals
    • Evelo Biosciences, Inc.

第11章 調査方法

  • 調査方法
    • データマイニング
    • 分析
    • 市場予測
    • 検証
    • 出版
  • 調査属性
  • 調査の前提条件
図表

List of Tables

  • TABLE 1. LIST OF SECONDARY SOURCES, USED IN THE STUDY OF GLOBAL HUMAN MICROBIOME MARKET
  • TABLE 2. LIST OF PRIMARY SOURCES, USED IN THE STUDY OF GLOBAL HUMAN MICROBIOME MARKET
  • TABLE 3. GLOBAL HUMAN MICROBIOME MARKET, REPORT SCOPE
  • TABLE 4. YEARS CONSIDERED FOR THE STUDY
  • TABLE 5. EXCHANGE RATES CONSIDERED
  • TABLE 6. GLOBAL HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS BY REGION 2016-2026 (USD MILLION)
  • TABLE 7. GLOBAL HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS BY PRODUCT 2016-2026 (USD MILLION)
  • TABLE 8. GLOBAL HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS BY APPLICATION 2016-2026 (USD MILLION)
  • TABLE 9. GLOBAL HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS BY DISEASE 2016-2026 (USD MILLION)
  • TABLE 10. GLOBAL HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS BY TECHNOLOGY 2016-2026 (USD MILLION)
  • TABLE 11. GLOBAL HUMAN MICROBIOME MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
  • TABLE 12. GLOBAL HUMAN MICROBIOME MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
  • TABLE 13. GLOBAL HUMAN MICROBIOME MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
  • TABLE 14. GLOBAL HUMAN MICROBIOME MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
  • TABLE 15. GLOBAL HUMAN MICROBIOME MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
  • TABLE 16. GLOBAL HUMAN MICROBIOME MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
  • TABLE 17. GLOBAL HUMAN MICROBIOME MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
  • TABLE 18. GLOBAL HUMAN MICROBIOME MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
  • TABLE 19. GLOBAL HUMAN MICROBIOME MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
  • TABLE 20. GLOBAL HUMAN MICROBIOME MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
  • TABLE 21. GLOBAL HUMAN MICROBIOME MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
  • TABLE 22. GLOBAL HUMAN MICROBIOME MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
  • TABLE 23. GLOBAL HUMAN MICROBIOME MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
  • TABLE 24. GLOBAL HUMAN MICROBIOME MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
  • TABLE 25. GLOBAL HUMAN MICROBIOME MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
  • TABLE 26. GLOBAL HUMAN MICROBIOME MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
  • TABLE 27. GLOBAL HUMAN MICROBIOME MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
  • TABLE 28. GLOBAL HUMAN MICROBIOME MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
  • TABLE 29. GLOBAL HUMAN MICROBIOME MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
  • TABLE 30. GLOBAL HUMAN MICROBIOME MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
  • TABLE 31. GLOBAL HUMAN MICROBIOME MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
  • TABLE 32. GLOBAL HUMAN MICROBIOME MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
  • TABLE 33. U.S. HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
  • TABLE 34. U.S. HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 35. U.S. HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 36. U.S. HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 37. U.S. HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 38. CANADA HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
  • TABLE 39. CANADA HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 40. CANADA HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 41. CANADA HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 42. CANADA HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 43. UK HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
  • TABLE 44. UK HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 45. UK HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 46. UK HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 47. UK HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 48. GERMANY HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
  • TABLE 49. GERMANY HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 50. GERMANY HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 51. GERMANY HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 52. GERMANY HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 53. ROE HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
  • TABLE 54. ROE HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 55. ROE HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 56. ROE HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 57. ROE HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 58. CHINA HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
  • TABLE 59. CHINA HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 60. CHINA HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 61. CHINA HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 62. CHINA HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 63. INDIA HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
  • TABLE 64. INDIA HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 65. INDIA HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 66. INDIA HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 67. INDIA HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 68. JAPAN HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
  • TABLE 69. JAPAN HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 70. JAPAN HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 71. JAPAN HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 72. JAPAN HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 73. ROAPAC HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
  • TABLE 74. ROAPAC HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 75. ROAPAC HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 76. ROAPAC HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 77. ROAPAC HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 78. BRAZIL HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
  • TABLE 79. BRAZIL HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 80. BRAZIL HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 81. BRAZIL HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 82. BRAZIL HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 83. MEXICO HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
  • TABLE 84. MEXICO HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 85. MEXICO HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 86. MEXICO HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 87. MEXICO HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 88. ROLA HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
  • TABLE 89. ROLA HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 90. ROLA HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 91. ROLA HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 92. ROLA HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 93. ROW HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
  • TABLE 94. ROW HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 95. ROW HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 96. ROW HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 97. ROW HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

List of Figures

  • FIG 1. GLOBAL HUMAN MICROBIOME MARKET, RESEARCH METHODOLOGY
  • FIG 2. GLOBAL HUMAN MICROBIOME MARKET, MARKET ESTIMATION TECHNIQUES
  • FIG 3. GLOBAL MARKET SIZE ESTIMATES & FORECAST METHODS
  • FIG 4. GLOBAL HUMAN MICROBIOME MARKET, KEY TRENDS 2018
  • FIG 5. GLOBAL HUMAN MICROBIOME MARKET, GROWTH PROSPECTS 2019-2026
  • FIG 6. GLOBAL HUMAN MICROBIOME MARKET, PORTERS 5 FORCE MODEL
  • FIG 7. GLOBAL HUMAN MICROBIOME MARKET, PEST ANALYSIS
  • FIG 8. GLOBAL HUMAN MICROBIOME MARKET, VALUE CHAIN ANALYSIS
  • FIG 9. GLOBAL HUMAN MICROBIOME MARKET BY SEGMENT, 2016 & 2026 (USD MILLION)
  • FIG 10. GLOBAL HUMAN MICROBIOME MARKET BY SEGMENT, 2016 & 2026 (USD MILLION)
  • FIG 11. GLOBAL HUMAN MICROBIOME MARKET BY SEGMENT, 2016 & 2026 (USD MILLION)
  • FIG 12. GLOBAL HUMAN MICROBIOME MARKET BY SEGMENT, 2016 & 2026 (USD MILLION)
  • FIG 13. GLOBAL HUMAN MICROBIOME MARKET BY SEGMENT, 2016 & 2026 (USD MILLION)
  • FIG 14. GLOBAL HUMAN MICROBIOME MARKET BY SEGMENT, 2016 & 2026 (USD MILLION)
  • FIG 15. GLOBAL HUMAN MICROBIOME MARKET BY SEGMENT, 2016 & 2026 (USD MILLION)
  • FIG 16. GLOBAL HUMAN MICROBIOME MARKET BY SEGMENT, 2016 & 2026 (USD MILLION)
  • FIG 17. GLOBAL HUMAN MICROBIOME MARKET BY SEGMENT, 2016 & 2026 (USD MILLION)
  • FIG 18. GLOBAL HUMAN MICROBIOME MARKET BY SEGMENT, 2016 & 2026 (USD MILLION)
  • FIG 19. GLOBAL HUMAN MICROBIOME MARKET BY SEGMENT, 2016 & 2026 (USD MILLION)
  • FIG 20. GLOBAL HUMAN MICROBIOME MARKET, REGIONAL SNAPSHOT 2016 & 2026
  • FIG 21. NORTH AMERICA HUMAN MICROBIOME MARKET 2016 & 2026 (USD MILLION)
  • FIG 22. EUROPE HUMAN MICROBIOME MARKET 2016 & 2026 (USD MILLION)
  • FIG 23. ASIA PACIFIC HUMAN MICROBIOME MARKET 2016 & 2026 (USD MILLION)
  • FIG 24. LATIN AMERICA HUMAN MICROBIOME MARKET 2016 & 2026 (USD MILLION)
  • FIG 25. GLOBAL HUMAN MICROBIOME MARKET, COMPANY MARKET SHARE ANALYSIS (2018)
目次

Global Human Microbiome Market is valued approximately at USD 291.08 million in 2018 and is anticipated to grow with a healthy growth rate of more than 25% over the forecast period 2019-2026. Human microbiome can be defined as the aggregate of all microbiota which resides on or inside human tissues and biofluids coupled with the corresponding anatomical sites in which they reside, comprising the skin, uterus, mammary glands, conjunctiva, ovarian follicles, biliary tract, placenta, seminal fluid, lung, saliva, oral mucosa, and gastrointestinal tract. Human microbiome consists of bacteria, fungi, viruses, protists and archaea. Also, a human body harbors microorganism having a ratio of 3:1 as contrasted to the number of human cells present. The relationship of most microbes with the human bodies varies from being mutualistic and commensal to neutral and harmful. Rising incidences of chronic diseases such as cancer, crohn's syndrome and bowel syndrome along with advancements in the field of microscopic research on human health are the few factors responsible for high CAGR of the market over the forecast period. For instance, In 2018, it was estimated that there were 9.5 million cancer deaths and 17.0 million new cancer cases worldwide. The global burden of cancer is expected to grow to 27.5 million new cancer cases and 16.3 million cancer deaths by 2040 due to the growth and aging of the population, according to the International Agency for Research on Cancer (IARC). Thus, the prevalence of chronic disease is on surging trend across the globe thereby, the need for human microbiome is also increased as it is proved as effective to defend the chronic diseases as well as facilitates a healthy immune system through which the market is growing at significant rate. Moreover, investigational new drug requirements for fecal microbiota aided with growing number of collaborations among market players is the major factor likely to offer lucrative growth opportunity to the market in the upcoming years. However, a lack of expertise as well as barriers in proving the causal link between dysbiosis and diseases are few factors anticipated to hampering the growth of global Smart Water Metering market during the forecast period.

The regional analysis of global Human Microbiome Market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region across the world as well as anticipated to exhibit at highest growth rate / CAGR over the forecast period 2019-2026. Factors such as the increasing prevalence of chronic diseases, rising awareness among people on preventive healthcare, high availability of funding for microbiome research, and rising acceptance of probiotic products thereby, impelling the demand for human microbiome across the world.

Major market player included in this report are:

  • Enterome Bioscience
  • Seres Therapeutics
  • 4D Pharma PLC
  • Ubiome, Inc.
  • E.I. Du Pont De Nemours and Company
  • Synlogic
  • Second Genome
  • Vedanta Biosciences, Inc.
  • Ferring Pharmaceuticals
  • Evelo Biosciences, Inc.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product:

  • Probiotics
  • Prebiotics
  • Foods
  • Medical Foods
  • Diagnostic Tests
  • Drugs

By Application:

  • Therapeutics
  • Diagnostics
  • By Disease:
  • Infectious Diseases
  • Inflammatory Diseases
  • Endocrine & Metabolic Disorders
  • Cancer
  • Other Diseases

By Technology:

  • Genomics
  • Proteomics
  • Metabolomics

By Region:

  • North America
    • U.S.
    • Canada
  • Europe
    • UK
    • Germany
  • Asia Pacific
    • China
    • India
    • Japan
  • Latin America
    • Brazil
    • Mexico
  • Rest of the World

Furthermore, years considered for the study are as follows:

  • Historical year - 2016, 2017
  • Base year - 2018
  • Forecast period - 2019 to 2026

Target Audience of the Global Human Microbiome Market in Market Study:

  • Key Consulting Companies & Advisors
  • Large, medium-sized, and small enterprises
  • Venture capitalists
  • Value-Added Resellers (VARs)
  • Third-party knowledge providers
  • Investment bankers
  • Investors

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2017-2026 (USD Million)
    • 1.2.1. Human Microbiome Market, by Product, 2017-2026 (USD Million)
    • 1.2.2. Human Microbiome Market, by Application, 2017-2026 (USD Million)
    • 1.2.3. Human Microbiome Market, by Disease, 2017-2026 (USD Million)
    • 1.2.4. Human Microbiome Market, by Technology, 2017-2026 (USD Million)
    • 1.2.5. Human Microbiome Market, by Region, 2017-2026 (USD Million)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Human Microbiome Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Type Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Human Microbiome Market Dynamics

  • 3.1. Human Microbiome Market Impact Analysis (2018-2026)
    • 3.1.1. Market Drivers
    • 3.1.2. Market Challenges
    • 3.1.3. Market Opportunities

Chapter 4. Global Human Microbiome Market Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Futuristic Approach to Porter's 5 Force Model (2016-2026)
  • 4.2. PEST Analysis
    • 4.2.1. Political
    • 4.2.2. Economical
    • 4.2.3. Social
    • 4.2.4. Technological
  • 4.3. Investment Adoption Model
  • 4.4. Analyst Recommendation & Conclusion

Chapter 5. Global Human Microbiome Market, by Product

  • 5.1. Market Snapshot
  • 5.2. Global Human Microbiome Market by Product, Performance - Potential Analysis
  • 5.3. Global Human Microbiome Market Estimates & Forecasts by Product 2016-2026 (USD Million)
  • 5.4. Human Microbiome Market, Sub Segment Analysis
    • 5.4.1. Probiotics
    • 5.4.2. Prebiotics
    • 5.4.3. Foods
    • 5.4.4. Medical Foods
    • 5.4.5. Diagnostic Tests
    • 5.4.6. Drugs

Chapter 6. Global Human Microbiome Market, by Application

  • 6.1. Market Snapshot
  • 6.2. Global Human Microbiome Market by Type, Performance - Potential Analysis
  • 6.3. Global Human Microbiome Market Estimates & Forecasts by Type 2016-2026 (USD Million)
  • 6.4. Human Microbiome Market, Sub Segment Analysis
    • 6.4.1. Therapeutics
    • 6.4.2. Diagnostics

Chapter 7. Global Human Microbiome Market, by Disease

  • 7.1. Market Snapshot
  • 7.2. Global Human Microbiome Market by Disease, Performance - Potential Analysis
  • 7.3. Global Human Microbiome Market Estimates & Forecasts by Disease 2016-2026 (USD Million)
  • 7.4. Human Microbiome Market, Sub Segment Analysis
    • 7.4.1. Infectious Diseases
    • 7.4.2. Inflammatory Diseases
    • 7.4.3. Endocrine & Metabolic Disorders
    • 7.4.4. Cancer
    • 7.4.5. Other Diseases

Chapter 8. Global Human Microbiome Market, by Technology

  • 8.1. Market Snapshot
  • 8.2. Global Human Microbiome Market by Technology, Performance - Potential Analysis
  • 8.3. Global Human Microbiome Market Estimates & Forecasts by Technology 2016-2026 (USD Million)
  • 8.4. Human Microbiome Market, Sub Segment Analysis
    • 8.4.1. Genomics
    • 8.4.2. Proteomics
    • 8.4.3. Metabolomics

Chapter 9. Global Human Microbiome Market, Regional Analysis

  • 9.1. Human Microbiome Market, Regional Market Snapshot
  • 9.2. North America Human Microbiome Market
    • 9.2.1. U.S. Human Microbiome Market
      • 9.2.1.1. Product breakdown estimates & forecasts, 2016-2026
      • 9.2.1.2. Application breakdown estimates & forecasts, 2016-2026
      • 9.2.1.3. Disease breakdown estimates & forecasts, 2016-2026
      • 9.2.1.4. Technology breakdown estimates & forecasts, 2016-2026
    • 9.2.2. Canada Human Microbiome Market
  • 9.3. Europe Human Microbiome Market Snapshot
    • 9.3.1. U.K. Human Microbiome Market
    • 9.3.2. Rest of Europe Human Microbiome Market
  • 9.4. Asia-Pacific Human Microbiome Market Snapshot
    • 9.4.1. China Human Microbiome Market
    • 9.4.2. India Human Microbiome Market
    • 9.4.3. Japan Human Microbiome Market
    • 9.4.4. Rest of Asia Pacific Human Microbiome Market
  • 9.5. Latin America Human Microbiome Market Snapshot
    • 9.5.1. Brazil Human Microbiome Market
    • 9.5.2. Mexico Human Microbiome Market
  • 9.6. Rest of The World Human Microbiome Market

Chapter 10. Competitive Intelligence

  • 10.1. Top Market Strategies
  • 10.2. Company Profiles
    • 10.2.1. Enterome Bioscience
      • 10.2.1.1. Key Information
      • 10.2.1.2. Overview
      • 10.2.1.3. Financial (Subject to Data Availability)
      • 10.2.1.4. Product Summary
      • 10.2.1.5. Recent Developments
    • 10.2.2. Seres Therapeutics
    • 10.2.3. 4D Pharma PLC
    • 10.2.4. Ubiome, Inc.
    • 10.2.5. E.I. Du Pont De Nemours and Company
    • 10.2.6. Synlogic
    • 10.2.7. Second Genome
    • 10.2.8. Vedanta Biosciences, Inc.
    • 10.2.9. Ferring Pharmaceuticals
    • 10.2.10. Evelo Biosciences, Inc.

Chapter 11. Research Process

  • 11.1. Research Process
    • 11.1.1. Data Mining
    • 11.1.2. Analysis
    • 11.1.3. Market Estimation
    • 11.1.4. Validation
    • 11.1.5. Publishing
  • 11.2. Research Attributes
  • 11.3. Research Assumption